JiangSu WuZhong Pharmaceutical Development Co., Ltd.

JiangSu WuZhong Pharmaceutical Development Co., Ltd.verified

600200.SS

Price:

$1.24

Market Cap:

$881.49M

JiangSu WuZhong Pharmaceutical Development Co., Ltd., together with its subsidiaries, engages in pharmaceutical, real estate, and chemical businesses in China. It develops, produces, and sells anti-infective, digestive system, cardiovascular, cerebrovascular, antiviral, vitamin, and hemostatic drugs; and immunomodulations, including biopharmaceuticals, chemical drugs, and modern Chinese medicines. The company offers its products in various forms, such as infusion solutions, water and powder injections, capsules, granules, tablets, emulsions, and oral liquids. It also engages in the research, development, production, and sale of dyes and dye intermediates; and the fields of commercial housing...[Read more]

Industry

Biotechnology

IPO Date

1999-04-01

Stock Exchange

SHH

Ticker

600200.SS

The PE Ratio as of December 2025 (TTM) for JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS) is -13.78

According to JiangSu WuZhong Pharmaceutical Development Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -13.78. This represents a change of -184.87% compared to the average of 16.24 of the last 4 quarters.

JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS) Historical PE Ratio (quarterly & annually)

How has 600200.SS PE Ratio performed in the past?

The mean historical PE Ratio of JiangSu WuZhong Pharmaceutical Development Co., Ltd. over the last ten years is 85.24. The current -13.78 PE Ratio has changed -1716.68% with respect to the historical average. Over the past ten years (40 quarters), 600200.SS's PE Ratio was at its highest in in the March 2024 quarter at 421.07. The PE Ratio was at its lowest in in the June 2023 quarter at -1707.29.

Quarterly (TTM)
Annual

Average

85.24

Median

61.05

Minimum

-82.20

Maximum

362.21

JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of JiangSu WuZhong Pharmaceutical Development Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 96.36%

Maximum Annual PE Ratio = 362.21

Minimum Annual Increase = -3659.42%

Minimum Annual PE Ratio = -82.20

Quarterly (TTM)
Annual
YearPE RatioChange
202493.20-213.38%
2023-82.2018.01%
2022-69.66-126.21%
2021265.80-3659.42%
2020-7.47-112.49%
201959.78-497.86%
2018-15.02-124.11%
201762.32-66.02%
2016183.40-49.37%
2015362.2196.36%

JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS) Average PE Ratio

How has 600200.SS PE Ratio performed in the past?

The current PE Ratio of JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-19.55

5-year avg

39.94

10-year avg

85.24

JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS) PE Ratio vs. Peers

How is 600200.SS’s PE Ratio compared to its peers?

JiangSu WuZhong Pharmaceutical Development Co., Ltd.’s PE Ratio is less than Shenzhen GuoHua Network Security Technology Co., Ltd. (-12.51), less than Changjiang Pharmaceutical Group Co., Ltd. (-1.11), greater than Tiansheng Pharmaceutical Group Co., Ltd. (-16.79), greater than Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (-139.43), greater than Jiangsu gdk Biotechnology Co., Ltd. (-25.84), greater than Sailong Pharmaceutical Group Co., Ltd. (-35.93), greater than Hainan Huluwa Pharmaceutical Group Co., Ltd. (-21.23), greater than Shandong Sito Bio-technology Co., Ltd. (-16.31), greater than Jiangsu Sihuan Bioengineering Co., Ltd (-24.20), less than Jiangsu Nanfang Medical Co., Ltd. (-9.60),

Build a custom stock screener for JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like JiangSu WuZhong Pharmaceutical Development Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like JiangSu WuZhong Pharmaceutical Development Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is JiangSu WuZhong Pharmaceutical Development Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS)?

What is the highest PE Ratio for JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS)?

What is the 3-year average PE Ratio for JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS)?

What is the 5-year average PE Ratio for JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS)?

How does the current PE Ratio for JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS) compare to its historical average?